The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
My buy this morning was marked sell btw, some manipulation going on.
MMs hold it back as long as possible and then it shoots up one or two hundred percent on news.
I've topped up twice today, Trump has killed Tik Tok whether they get a deal or not. Triller is the future in my opinion.
The McGregor vs Mayweather pay-per-view was like $100.
Fortunately for Triller, people do pay such extortionate figures.
@Jon_Bon In the latest interview with IG, 4D Pharma's CEO said they should have news on US investment in weeks/months so hopefully not too long if he's mentioning weeks.
Anyone with L2 verify that those are all sells that I'm seeing? Can't believe so many people would sell at 140p.
...has an account on Triller.
I think Triller has won the battle.
Bieber also has an account.
Been looking at Triller this morning. Noticed Idris Elba has an account, his first video has 1.1 million views.
Hmm, my £5k buy is reported as a sell....
@Trendz I tried topping up this share on the morning of the cancer RNS, I could not buy anything until the very peak and then of course the SP retreated 15% as the profit takers sold off. Definitely a learning experience and a case for buying and holding long-term.
Hefty buys just before close and larger buys from 3:30pm delayed until close, big MM games played today.
Yeah, people have been busy giving the MMs their shares today so hopefully they're satisfied and we'll go up from here.
They need hospitalised participants for their trial and Plymouth is a relatively quite area. 4D may need to expand their trial to new locations if they are to have any success.
A link to the 4D Pharma Covid study:
https://clinicaltrials.gov/ct2/show/NCT04363372?term=NCT04363372&draw=2&rank=1
In summary, it is a single-strain gut bacteria that can potentially calm the overactive immune response (preventing the need for a ventilator) while allowing the body to fight off the virus. It's a very novel approach to treat the inflammation and allow the body's defences to fight off the virus.
I guess the Covid study is back in play. We'll have to monitor hospital cases in University Hospitals Plymouth NHS Trust where the study is taking place. Don't forget 4D is a covid Pharma stock.
Every day that passes, I think this is going to be the share that everyone talks about from AIM. Whether we get a revolution in cancer treatment or IBS or Neurodegeneration or Covid or maybe the MicroRx platform earns huge licencing fees, there's so much potential from just one company. They've even got a presentation in Mandarin on their website so they are doing everything right in my opinion.
I think people may regret not ploughing money into this share while it's still relatively cheap in comparison to competitors like Seres Therapeutics. Let's hope for another week of daily SP climbing as investors gradually discover this great overlooked stock.
Hi Jon, hopefully the Friday sellers will buy back in on Monday morning so should be a sharp 8AM-9AM spike.
A week ago, I thought the same as you about SP pulling back without an RNS but there's heavy "fear of missing out (FOMO)" going on right now. The SP might just keep ticking up due to the repeated £75K-£100K buys we're seeing.
This is just my opinion, know the risks and do your own research of course.
I think we'll need the NASDAQ listing if we want to see £10 this year. In the latest interview Duncan (4D Pharma CEO) mentioned a timescale of weeks or months before some form of US investment so hopefully this year.
This isn't any old pharma stock, it's a new class of drugs in the form of gut bacteria. It's here to stay.
I'm hoping for a lot more than £10 once 4D pharma or one of its competitors gets a drug to market and effectively proves the value of gut bacteria in treating a range of diseases.